−0.0277USD
−1.49 MUSD
863.82 KUSD
12.73 M
About Remedent, Inc.
Sector
Industry
CEO
Guy de Vreese
Website
Headquarters
Ghent
Employees (FY)
3
Founded
1996
FIGI
BBG000BVWLY9
Remedent, Inc. engages in the research, development, and manufacturing of dental products and oral hygiene products. Its products include river 8, prefab veneer, and condor. The company was founded on September 30, 1996 and is headquartered in Ghent, Belgium.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of REMI is 0.0550 USD — it has decreased by 15.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Remedent, Inc. stocks are traded under the ticker REMI.
Remedent, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
REMI stock is 18.82% volatile and has beta coefficient of 0.77. Check out the list of the most volatile stocks — is Remedent, Inc. there?
Yes, you can track Remedent, Inc. financials in yearly and quarterly reports right on TradingView.
REMI net income for the last quarter is 36.04 K USD, while the quarter before that showed −29.51 K USD of net income which accounts for 222.13% change. Track more Remedent, Inc. financial stats to get the full picture.
No, REMI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, REMI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Remedent, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 3.00 employees. See our rating of the largest employees — is Remedent, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Remedent, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Remedent, Inc. stock shows the sell signal. See more of Remedent, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Remedent, Inc. EBITDA is −58.47 K USD, and current EBITDA margin is −29.84%. See more stats in Remedent, Inc. financial statements.